SCHEMBL2196104

SCHEMBL2196104

CO[Si](C)(CCc1ccccc1C)OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.48
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
ALOX12 P18054 1/20 0.37
KMT2A Q03164 1/20 0.37
P2RX7 Q99572 2/20 0.36
CYP2A13 Q16696 1/20 0.36
DAO P14920 1/20 0.36
MAOB P27338 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1031551 0.88 MTNR1A (0.37) TAAR1MAPTLMNAALDH1A1CHRM2
SCHEMBL2203418 0.82 TAAR1 (0.50) TAAR1ADRA2AADRA2BADRA2CMEN1
SCHEMBL12365048 0.79 TAAR1 (0.56) TAAR1ADRA2AADRA2BADRA2CP2RX7
SCHEMBL3339281 0.79 MTNR1A (0.33) TAAR1KMT2AALDH1A1
SCHEMBL8759222 0.78 TAAR1 (0.50) TAAR1ADRA2AADRA2BADRA2CP2RX7
SCHEMBL12585379 0.78 TAAR1 (0.46) TAAR1ADRA2AADRA2BADRA2CMEN1
SCHEMBL30081115 0.76 TAAR1 (0.41) TAAR1ADRA2AADRA2BADRA2CKMT2A
SCHEMBL8759198 0.76 TAAR1 (0.52) TAAR1ADRA2AADRA2BADRA2CMEN1
SCHEMBL1639326 0.76 PTGS2 (0.33)
SCHEMBL8759213 0.76 TAAR1 (0.47) TAAR1ADRA2AADRA2BADRA2CKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12567521-B2 Method for injecting strand-blocked cable NOVINIUM, LLC (US) 2026-03-03 US claimed
US-12165784-B2 Method for injecting strand-blocked cable NOVINIUM, LLC (US) 2024-12-10 US claimed
US-20240266091-A1 METHOD FOR INJECTING STRAND-BLOCKED CABLE NOVINIUM, INC. 2024-08-08 US claimed
US-12009119-B2 Method for injecting strand-blocked cable NOVINIUM, LLC (US) 2024-06-11 US claimed
WO-2023114695-A1 APROTIC CATALYSTS FOR THE HYDROLYSIS/CONDENSATION OF ORGANOALKOXYSILANES NOVINIUM, LLC (US) 2023-06-22 WO claimed
US-20230183426-A1 APROTIC CATALYSTS FOR THE HYDROLYSIS / CONDENSATION OF ORGANOALKOXYSILANES NOVINIUM, LLC 2023-06-15 US claimed
EP-4115482-A1 METHOD FOR INJECTING STRAND-BLOCKED CABLE Novinium, Inc. (US) 2023-01-11 EP claimed
US-20220375655-A1 METHOD FOR INJECTING STRAND-BLOCKED CABLE OBI PARTNERS, LLC 2022-11-24 US claimed
CN-115322377-A Pre-condensed power cable insulation aging repair liquid and preparation method and application thereof 广东电网有限责任公司广州供电局 2022-11-11 CN claimed
WO-2021178686-A1 METHOD FOR INJECTING STRAND-BLOCKED CABLE NOVINIUM, INC. (US) 2021-09-10 WO claimed
US-20210280341-A1 METHOD FOR INJECTING STRAND-BLOCKED CABLE OBI PARTNERS, LLC 2021-09-09 US claimed
US-8967178-B2 Saturation valve assembly for electric cables UTILX CORPORATION (US) 2015-03-03 US claimed
US-8572842-B2 Method for thermally enhancing injection of power cables NOVINIUM, INC. (US) 2013-11-05 US claimed
US-20130276907-A1 VALVE ASSEMBLY UTILX CORPORATION (US) 2013-10-24 US claimed
US-7976747-B2 Method for restoring power cables NOVINIUM, INC. (US) 2011-07-12 US claimed
US-20100122453-A1 THERMALLY ENHANCED POWER CABLE REJUVENATION TECHNOLOGY RESEARCH, LLC 2010-05-20 US claimed
US-20090133799-A1 METHOD FOR RESTORING POWER CABLES NOVINIUM, LLC 2009-05-28 US claimed
US-12567521-B2 Method for injecting strand-blocked cable NOVINIUM, LLC (US) 2026-03-03 US disclosed
WO-2005084321-A2 METHOD FOR TREATING ELECTRICAL CABLE AT SUSTAINED ELEVATED PRESSURE NOVINIUM, INC. (US) 2005-09-15 WO disclosed
WO-2005084322-A2 METHOD FOR SELECTING FORMULATIONS TO TREAT ELECTRICAL CABLES NOVINIUM, INC. (US) 2005-09-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12567521-B2 Method for injecting strand-blocked cable MMP1, POT1, TELO2 TAAR1 1834/4885ADRA2A 2215/4885ADRA2B 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.